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Highlights: 
1) Synthesis of cis-[Ru(2,2'-bipyridine)2(4-benzoylpyridine)(CO)](PF6)2 (I). 
2) Synthesis and structure of cis-[Ru(2,2'-bipyridine)2(4-benzoylpyridine)Cl](PF6)2 (II). 
2) Ultraviolet photolysis of I sequentially releases benzoylpyridine and CO. 
3) Blue light photolysis of I releases only benzoylpyridine. 
4) Blue light photolysis of II can replace the 4-benzoylpyridine with guanine.  
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Abstract 
The ruthenium(II) compounds cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 (I) and cis-[Ru(bpy)2(4-
bzpy)(Cl)](PF6) (II) (4-bzpy = 4-benzoylpyridine, bpy = 2,2’-bipyridine) were synthesized 
and characterized by spectroscopic and electrochemical techniques. The crystal 
structure of II was determined by X-ray diffraction. The photochemical behavior of I in 
aqueous solution shows that irradiation with ultraviolet light (365 nm) releases both 
CO and 4-bzpy leading to the formation of the cis-[Ru(bpy)2(H2O)2]2+ ion as identified 
by NMR and electronic spectroscopy. Carbon monoxide release was confirmed with 
the myoglobin method and by gas chromatographic analysis of the headspace. CO 
release was not observed when aqueous I was irradiated with blue light (453 nm). 
Changes in the electronic and 1H NMR spectra indicate that I undergoes photoaquation 
of 4-bzpy to form cis-[Ru(bpy)2(CO)(H2O)]2+. Blue light irradiation of aqueous II 
released the coordinated 4-bzpy to give the cis-[Ru(bpy)2(H2O)(Cl)]2+ ion.  When the 
latter reaction was carried out in the presence of the nucleobase guanine, Ru-guanine 
adducts were formed, indicating that the metal containing photoproduct may also 
participate in biologically relevant reactions. The photochemical behavior of I indicates 
that it can release either CO or 4-bzpy depending on the wavelength chosen, a feature 
that may have therapeutic application.  
 
Keywords: photorelease; carbon monoxide; metallodrug; ruthenium
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Introduction 
 There has been considerable interest in recent years regarding the use of 
photoactive metal complexes for therapeutic applications [1,2]. In this context, the 
ruthenium(II) bis(bipyridyl) complexes are well known for their photophysical and 
photochemical properties and have been explored for biomedical and biophysical 
applications [1]. Due to their synthetic versatility, these are good candidates for photo-
activated prodrugs [2-5] with some being subjected to clinical and preclinical trials [6]. 
For examples, Turro and coworkers have explored the photo-uncaging of various 
ligands that have chemo-therapeutic activity from such platforms [10-12].  Etchenique 
and coworkers previously reported the photo-controlled release of a pyridine 
derivative bound to a ruthenium(II) bis(bipyridine) center.  This ligand was 4-
aminopyridine , which is neurochemical agent that blocks K+ channels [7]. This lab has 
also prepared a series of other metal-based photoreleasing systems [8].  In a different 
approach, Sadler et al. [4] have described the photochemical and nucleobase binding 
properties of intermediates formed by photo-labilization of Cl– from cis-
[Ru(bpy)2(CO)Cl]+  and concluded that this strategy provides valuable leads for new 
photo-activated antitumor ruthenium complexes. However, Ru-Cl bond hydrolysis also 
occurs in the dark, rendering that compound less-specific for photo-drug applications. 
 The present work was initiated to examine how changing the ligand (L) in 
complexes of the type cis-[Ru(bpy)2(CO)L]+ changes the photochemical properties of 
these species. Here we describe the synthesis, characterization and photochemical 
properties of the new complex salts cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 (I) and cis-
[Ru(bpy)2(4-bzpy)(Cl)](PF6) (II), where 4-bzpy = 4-benzoylpyridine, a p-acceptor ligand. 
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The ligand 4-benzoylpyridine was chosen because presents a more extended π -system 
in comparison to other pyridine ligands previously used in ruthenium-based NO 
donors, cis-[Ru(bpy)2L(NO)]n+ (L = pyridine, picoline, 4-acetylpyridine, isonicotinamide) 
[9, 10]. . Additionally, It was observed that blue light photolysis (453 nm) of either I or 
II leads to labilization of 4-bzpy, while near-UV photolysis (365 nm) of I also leads to CO 
release. 
 Carbon monoxide is a small molecule bioregulator in mammalian physiology 
that may play key roles in wound healing, cytoprotection during inflammation and 
prevention of ischemia/reperfusion injury [11, 12].  These properties have engendered 
interest in developing strategies for CO delivery to physiological targets including  
thermally and photochemically activated CO-releasing moieties (CORMs, [12] and  
photoCORMs [13-15], respectively). For the latter, using light as the trigger can define 
the location, timing and dosage of CO release. Although optimal transmission of light 
through mammalian tissue requires red or near infrared wavelengths, shorter 
wavelength excitation may have value in treatment of subcutaneous cancers [16, 17] 
and bacterial infections [20].  
 The metal containing product from photoreactions of a photoCORM may also 
be biologically active and offer some therapeutic potential. One might draw inspiration 
from the action of cisplatin, which crosslinks with DNA purine bases. However, 
cisplatin use is dose-limited due to systemic toxicity, primarily to the kidney [18].  An 
alternative strategy would be to use complexes that are inactive in the dark but react 
with nucleobases upon irradiation [11,12]. In this context, it is notable the products 
generated upon photolysis of II display nucleobase binding properties. 
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Experimental Section 
 Materials: Ultrahigh purity water from a Millipore system (model: Millipore 
Direct Q® 3UV) was used throughout the experiments. RuCl3·xH2O, 4-benzoylpyridine 
and 2,2’-bipyridine were purchased from Sigma-Aldrich and used without further 
purification. cis-[Ru(bpy)2Cl2] (III) was prepared according to a procedure described in 
the literature [19]. 
 Synthesis of the complexes:  cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6).H2O (II): A solution 
was prepared by mixing a sample of III (0.200 g, 0.41 mmol) and 4-benzoylpyridine 
(0.080g, 0.43 mmol) in a 1:1 ethanol/water solution (20 mL). This mixture was heated 
at reflux for 3 h. The resulting solution was concentrated by rotary evaporation to a 
volume of 10 mL. The solid II was precipitated by the addition of saturated aqueous 
NH4PF6 solution (2 mL), collected by filtration and washed with cold water.  Yield = 87 
%. IR (KBr disks, nmax/cm-1): 3117 (C-H); 1667 (C=O, ketone group); 1446 (C-N); 1H NMR 
(500 MHz, d6-acetone, δ): 8.62 (d, bzpy-H21,21’, J = 5.50 Hz); 7.61 (d, bzpy-H22,22’, J = 
6.00Hz); 7.83 (d, bzpy-H26,26’, J = 7.00 Hz); 7.52 (t, bzpy-H27,27’, J = 7.70 Hz); 7.73 (t, 
bzpy-H28, J = 6.90 Hz).  Analysis: Calcd. for C32H27ClF6N5O2PRu. Exp. (calc): C, 48.58 
(48.34); H, 3.41 (3.42); N, 8.85 (8.81)%.  We also report the X-ray crystal structure of 
this compound (see below) 
 cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2.H2O(I): The reaction was carried out in a 
Schlenk flask connected to a CO gas line. A sample of cis-[Ru(bpy)2(4-bzpy)Cl]PF6 (0.100 
g, 0.14 mmol)  diluted in dimethylformamide (3.0 mL) was stirred under CO (1 atm) at 
120 oC for 120 h. The solid was precipitated by the addition of saturated aqueous 
NH4PF6 solution (2 mL), collected by filtration and washed with cold water. Yield = 93%.   
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IR spectrum (KBr disk, nmax/cm-1): 3117 (C-H); 1446 (C-N), 1665 (C=O, ketone group), 
1962 (CºO carbonyl ligand); 1H NMR (500 MHz, acetone-d6, δ): 9.10 (d, bzpy-H21,21’, J = 
5.50 Hz); 8.06 (d, bzpy-H22,22’, J = 6.00 Hz); 7.89 (d, bzpy-H26,26’, J = 7.00 Hz); 7.57 (t, 
bzpy-H27,27’, J = 7.70 Hz); 7.76 (t, bzpy-H28, J = 6.90 Hz). Analysis: Calcd. for 
C33H27F12N5O3P2Ru. Exp.(calc): C, 42.49 (42.50); H, 2.89 (2.92); N, 7.51 (7.51)%. 
 Instrumentation: Electrochemical experiments were performed in a BAS Epsilon 
2 818 electrochemical analyzer from Bioanalytical Systems. These measurements were 
performed using millimolar solutions of the complexes in acetonitrile as solvent and 
tetrabutylammonium perchlorate (TBAP) 0.1 M as supporting electrolyte. A 
conventional three-electrode glass cell was used with glassy carbon (ca. 0.13 cm2 
geometrical area), Pt foil, and Ag/AgCl (filled with acetonitrile containing 0.1 M TBAP) 
working, auxiliary and reference electrodes, respectively. The electrochemical 
experiments were conducted at room temperature.  
 FTIR spectra were recorded for compounds I and II in KBr pellets using an ABB 
Bomem FTLA 2000-102 spectrophotometer.  NMR spectra were recorded using a 
Bruker AVANCE DPX500 spectrometer in acetone-d6. Photoproducts formed upon 
irradiation of I and of II in DMSO-d6/D2O (20/80, v/v) and DMSO-d6/D2O (5/95, v/v) 
solutions, respectively, were characterized by recording their NMR and optical 
absorption spectra. Electronic spectra were recorded on a HP-8453 diode-array 
spectrophotometer. 
  X-ray diffraction studies of single crystals of II were carried out on an Enraf–
Nonius Kappa CCD diffractometer, using Mo K(a) radiation (0.71073 Å). Data collection 
used the COLLECT program [20], and integration and scaling of the reflections were 
performed with the HKL Denzo-Scalepack system of programs [21]. Absorption 
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corrections were carried out by using the multi-scan method [22]. The structure was 
solved by direct methods with SHELXS-97 [23]. The models were refined by full-matrix 
least-squares on F2 with SHELXL-97 [24]. All the hydrogen atoms were 
stereochemically positioned and refined with the riding model. 
Photolysis experiments were carried out at room temperature in 1.0 cm path 
length quartz cells capped with rubber septa. The solutions were deaerated by 
bubbling argon prior to photolysis and stirred during irradiation. Simultaneous dark 
reactions were carried out with identical solutions as controls. The UV-Vis spectra of 
the latter solutions showed these samples to be stable in the dark at least during the 
time scale of the photochemical experiments.  Quantitative analysis of product 
formation and disappearance of the starting materials was carried out by monitoring 
the electronic spectral changes (see below).  
Continuous photolysis was performed using a blue LED (lmax = 453 nm) or with 
the output from a 200 W high pressure mercury lamp mounted on an Oriel optical 
train passed through an interference filter to isolate the mercury line at 365 nm. 
Lenses were used to collimate the light beam and a shutter was used to control the 
irradiation time.  The light intensity was determined using chemical actinometry with 
potassium trisoxalatoferrate(III) [25, 26]. In general, incremental quantum yields 
determined from incremental spectral changes were plotted versus the percent 
reaction and extrapolated back to 0% reaction to minimize inner filter effects. A linear 
fit of these data over the first 25-30% of the reaction provided a y-intercept equal to 
the initial quantum yield. Each reported quantum yield is the average of, at least, three 
independent experiments. For the primary photoreaction of compound I, quantum 
yields were determined by plotting the incremental quantum yields for the absorbance 
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decrease at 415 nm versus the elapsed irradiation time as shown in Supporting 
Information (SI) Figures S1 and S2, respectively. For the secondary photoreaction of I 
seen with 365 nm irradiation, the spectral changes were measured after 2 min of 
irradiation, when the primary reaction was effectively complete. In this case, the 
quantum yield was determined by plotting the incremental quantum yields after the 
first 2 min as calculated from further absorbance decreases at 415 nm versus the 
elapsed irradiation time (SI Figure S3).  For photolysis of compound II, the quantum 
yield was determined by plotting incremental quantum yields for the decrease of a 
band at 440 nm versus the elapsed irradiation time as shown in SI Figure S4. 
 Interaction with guanine: An NMR sample was prepared by dissolving 8.4 mg of 
II in 0.035 mL of DMSO-d6. To this was added a 0.665 mL aliquot of a guanine stock 
solution prepared by dissolving 24.8 mg of guanine in 5 mL of warm D2O/NaOH (0.02 
M) solution under stirring.  The guanine stock solution was added dropwise with 
stirring to avoid precipitation of the compound. The reaction during 453 nm photolysis 
of the solution was followed by NMR and electronic spectra for 2 h until the 
photoreaction is complete. The photoproduct solution was then stirred for 24 h to 
react with guanine after which NMR and electronic spectra were again obtained.  
 Analysis of CO release: The myoglobin assay [28] was used to evaluate 
photochemical CO release from cis-[Ru(bpy)2(4-bzpy)CO](PF6)2. In this assay, 
conversion from deoxy-myoglobin (Mb) to carbonmonoxy-myoglobin (MbCO) was 
monitored using a Cary 5000 UV-Vis-NIR/Varian spectrophotometer. All experiments 
were carried out under anaerobic conditions using a glove box (COY laboratories). For 
a typical measurement, myoglobin was dissolved in 1000 µL of 0.1 M phosphate buffer 
(pH 7.3), resulting in a 48 µM solution, placed in a 1 cm quartz cuvette and degassed 
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with argon. Subsequently, a 2X excess of sodium dithionite was added to convert met-
Mb to deoxy-Mb. Due to the insolubility of I in aqueous buffer, a stock solution (~96 
µM) was prepared in methanol, and a aliquot of this stock solution (1000 µL) plus PBS 
buffer were then added to the deoxy-Mb solution to give a total volume 4000 µL and  
a final solution containing I (24 µM), myoglobin (12 µM) and dithionite (24 µM). The 
cuvette was sealed with a plug to prevent escape of CO or reoxidation of the 
myoglobin. The solution was initially kept in the dark to study the stability of the 
complex in aqueous buffer and then was illuminated using UV light (350 nm) until no 
further spectral changes could be observed for several consecutive measurements. 
Illuminations were interrupted in regular intervals to record the optical absorption 
spectrum. A dark control experiment was performed under the same conditions. This 
procedure was also followed using blue light (453 nm); however, there was no 
evidence for CO release in the latter case.    
 GC Analysis of CO release: The experiment was carried out as follows: A sample 
of I (15 mg) in a DMSO/H2O (20/80, v/v) solution under 1 atm of argon in a Schlenk 
cuvette was photolyzed for 2 h using 365 nm light. The solution was allowed to 
equilibrate with the gas phase by shaking repeatedly for 2-3 min. A 500 μL sample of 
the gas phase from the Schlenk cell was then removed with a gastight syringe and the 
CO content was determined by gas chromatography with thermal conductivity 
detection (GC-TCD) using a programmable Agilent model 6890 GC with a 10 m 
Carbosieve packed column. The injection port was maintained at 50 oC and the 
detector at 250 oC. The carrier gas was helium at a flow of 7.3 mL.min-1. The column 
was maintained at 35 oC for 5 min, raised at 40 oC. min-1 to 250 oC and held for 45 min. 
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Carbon monoxide is well resolved with this configuration and is detected with an 
elution time of ca. 8.0 min.   
 
Results 
 Syntheses and characterizations: The complex salt cis-[Ru(bpy)2(4-
bzpy)(Cl)](PF6) (II) was prepared and isolated from the reaction of cis-[Ru(bpy)2Cl2] (III) 
with 4-benzoyl pyridine  and characterized using NMR and infrared spectroscopy and 
elemental analysis.  In addition, the X-ray crystal structure of II was obtained. The IR 
spectra of both showed bands characteristic of the n(C=N) and n(C=C) bonds for 4-bzpy 
and overlapping bands of the bpy ligand in the range of 1610–1400 cm-1. A band at 
1665 cm-1 is attributed to n(C=O) of the ketone group of 4-bzpy that is absent in the IR 
spectrum of the precursor III (SI Figure S5).  
 The structure of II was confirmed by X-ray diffraction studies of crystals 
obtained by slow evaporation from methanol. Crystal data and structure refinement 
for this complex are summarized in Table 1 and the ORTEP projection is shown in the 
Figure 1. Selected bond lengths and angles are given in Table 2. The structure confirms 
the assignment of cis geometry of the chloride ligand in relation to 4-bzpy ligand 
suggested by the synthetic route. The Ru-N(bpy) bond lengths for Ru-N1 (2.052), Ru-
N2 (2.064) and Ru-N3 (2.074 Å), each are trans to a nitrogen ligand, are quite similar, 
while that of Ru-N4 (1.965), trans to a chloride, is somewhat shorter. These results are 
in agreement with structures determined for related complexes [27]. The presence of 
a single PF6- ion confirms that the ruthenium is in the Ru(II) oxidation state.  
 Complex II was further characterized by 1H NMR and 2D COSY spectroscopy and 
this is analyzed in the Supporting Information (SI Figure S6). All 16 signals for the H's of 
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the two bipyridines were observed suggesting all H atoms are magnetically non-
equivalent[28, 29], as expected for the cis-[Ru(bpy)2(4-bzpy)Cl]+ complex. 
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Table 1.  Crystal data and structure refinement for cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6) (II). 
 
Empirical formula  (C32H25N5OClRu)+.PF6- 
Formula weight  777.06 
Crystal system  Monoclinic 
Space group  P21/c 
Temperature  293(2) K 
Crystal size 0.3 x 0.2 x 0.1 mm3 
Unit cell dimensions a = 11.42(4) Å 
 b = 21.24(6) Å b= 99.8(2)° 
 c = 15.31(6) Å 
Volume 3660(23) Å3 
Z 4 
Absorption coefficient 0.607 mm-1 
F(000) 1560 
Reflections collected 23911 
Independent reflections 5819 [R(int) = 0.0973] 
Goodness-of-fit on F2 1.015 
Final R indices [I>2s(I)] R1 = 0.0809, wR2 = 0.1755 
R indices (all data) R1 = 0.2153, wR2 = 0.1945 
CCDC ref number 1487399 
a  Data collection, data processing, structure solution and structure refinement, respectively. 
 
Figure 1. ORTEP 5 view of the complex cation of II, showing atom labeling and the 50% 
probability ellipsoids. 
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Table 2. Selected Bond lengths [Å] and angles [°] for cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6) (II). 
        Bond lengths (Å)  Bond angles (o) 
Ru-N4 1.965(14) N4-Ru-N1 91.2(3) 
Ru-N1 2.052(9) N1-Ru-N3 95.0(4)                                                          
Ru-N2 2.064(9) N2-Ru-N3 174.4(4) 
Ru-N3 2.074(10) N2-Ru-N5 96.0(5) 
Ru-N5 2.125(9) N1-Ru-N5 176.0(3) 
Ru-Cl 2.408(10) N4-Ru-Cl 173.7(4) 
N1-C1 1.351(10) N2-Ru-Cl 86.3(3) 
N1-C5 1.355(11) N5-Ru-Cl 91.1(3) 
N2-C6 1.327(11) C1-N1-C5 116.6(8) 
N2-C10 1.354(10) C1-N1-Ru 128.3(8) 
O1-C26 1.313(16) C25-N5-Ru 118.9(9) 
C22-C23 1.326(13) O1-C26-C2) 122.5(17) 
C23-C24 1.386(13) O1-C26-C23 116.8(15) 
C24-C25 1.396(12) C27-C26-C23 120.5(16) 
C26-C27 1.384(16) C26-C27-C28 129.1(17) 
 
The well-characterized complex II was used to prepare cis-[Ru(bpy)2(4-
bzpy)(CO)](PF6)2 (I) by reaction with CO. The IR spectrum of the isolated compound 
showed a strong ν(CO) band at 1962 cm-1 within the range noted for other Ru(II)-CO 
compounds [30, 31], confirming the presence of coordinated CO (SI Figure S-7). The IR 
spectrum of I also exhibited vibrational bands corresponding to the n(C=N) and n(C=C) 
modes of the 4-benzoylpyridine ligand with overlapping bands of the bipyridine ligands 
in the range of 1610–1400 cm-1 [32] and the strong band at 1665 cm-1 attributed to the 
ketone n(C=O) of 4-bzpy, consistent with continued coordination of this ligand after 
exchange of chloride for CO, as is the elemental analysis. Analogous bands are 
observed in the IR spectrum of II (SI Figure S7) and of other 4-bzpy complexes such as 
fac-[Re(Cl)(4-bzpy)2(CO)3] and fac-[Re(Cl)(4-bzpy)2(CO)3] [33].  
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The carbonyl complex I was further characterized by 1H NMR, 13C NMR, and 
HMBC (Heteronuclear Multiple-Bond Correlation) spectroscopy. Figure 2 illustrates the 
HMBC spectrum for cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2, where 1H nuclei are correlated to 
remote 13C nuclei (two or three bonds away) in a 2D experiment via long-range 
heteronuclear J couplings (2JCH and 3JCH) [34]. This experiment shows CO resonances at 
low field (d 194.30 and d 200.48 ppm). Only the first is correlated with H's in 
neighboring bonds, and this was assigned to the ketone carbonyl of the 4-bzpy ligand. 
The signal at d 200.48 ppm can be assigned to the CO ligand, whereas coordinated 
carbonyls typically appear in the 13C NMR spectrum in the range of 180-250 ppm [4, 
33, 35]. The cross peak between the ketone carbon and the peaks at d 7.89 and d 8.06 
ppm observed in the HMBC experiment locates the two doublet signals of protons 
corresponding to H-29/H-33 and H-23/H-25, respectively, shown in Figure 2A. The 1H 
NMR spectrum showed signals for the other hydrogens present in the 4-bzpy ligand, 
two triplets at 7.57 and 7.76 ppm, assigned to the H-30/H-32 and H-31, respectively. 
All the signals are shifted downfield from those observed for the free ligand. This effect 
is even more pronounced for H-22/H-26 (d 9.10 ppm versus d 8.81 in free), due to 
proximity to the ruthenium center. Additionally, the 16 signals seen for the bipyridine 
hydrogens indicate that all H's are magnetically nonequivalent [36, 37]  as expected for 
the cis configuration this cation. 
Cyclic voltammetry (SI Figure S8) revealed quasi-reversible events with 
E1/2(Ru2+/3+) values of –0.11, 0.55 and 1.15 V vs Ag/AgCl (which would be the 
equivalent of 0.01, 0.56 and 1.34 vs Fc/Fc+) and DEp values of 0.10, 0.09 and 0.11 V for 
the respective complex compounds III, II and I.  Replacing one chloride of cis-
[Ru(bpy)2(Cl2)] by the p-acceptor ligand 4-bzpy to give cis-[Ru(bpy)2(4-bzpy)(Cl)]+ leads 
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to an anodic shift of the redox potential by 0.66 V (-0.11 vs 0.55V). Replacing the 
second chloride by CO to give I leads to a further anodic shift of 0.60 V. Thus, these p-
acceptor ligands (4-bzpy and CO) stabilize the ruthenium d-orbitals, and the Ru(II) 
center is much less readily oxidized.  
 
 
Figure 2. A) Drawing of cis-[Ru(bpy)2(4-bzpy)(CO)]2+. B) HMBC spectrum of I in CD3COCD3. 
 
The electronic absorption spectra of the cis-[Ru(bpy)2(4-bzpy)L]+/2+ complexes 
in DMSO/H2O (20/80, v/v) solution (SI Figures S9 and S10) display strong bands in the 
     A 
B 
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ultraviolet region and somewhat weaker bands in the visible.  For I (L = CO), these 
bands occur at 274 nm (e = 2.01 x 104 M-1 cm-1), 303 nm (6.93 x 103 M-1 cm-1) and 415 
nm (5.90 x 103 M-1 cm-1), while for II (L = Cl–) analogous bands occur at 315 nm (e = 
2.20 x 104 M-1 cm-1), 345 nm (7.93 x 103 M-1 cm-1) and 440 nm (1.24 x 104 M-1 cm-1).  
The UV absorption spectrum of free 4-bzpy displays a strong peak at 264 nm and a 
shoulder at 223 nm [38]. Although free 4-bzpy has a relatively low-lying np* excited 
state involving a ketone oxygen nonbonding orbital [33], these strong bands are π*¬π 
(4-bzpy) in origin.  The higher energy strong bands observed in the spectrum for the 
cis-[Ru(bpy)2(4-bzpy)L]+/2+ complexes are likely to be largely ligand localized transitions 
of the type (π*¬π(bpy) , π*¬π (4-bzpy), π*¬n(4-bzpy) although these may overlap 
with π*(bpy)¬dπ(Ru) metal to ligand charge transfer (MLCT) transitions. In analogy 
with other Ru(II) complexes [39, 40], the weaker visible range band seen for each 
complex can be assigned to a MLCT transition.  Notably, this band occurs at higher 
energy for the carbonyl complex I than for the chlorido analog II. This effect can be 
attributed to the π*(CO)¬dπ(Ru) backbonding interaction that stabilizes the dπ(Ru) 
orbitals in I.  
 Photochemical Studies: The photochemical behavior of I in DMSO/H2O (20/80, 
v/v) solution was found to be complex, where there was no clear isosbestic point.  
From Figure 3, it is evident that the electronic spectra of photoproducts formed upon 
irradiation with blue light (lirr = 453 nm) (dotted line) and with UV light (lirr = 365 nm) 
(dashed line) are different. Photolysis with blue light leads to the appearance of a new 
absorption band at ca. 450 nm while UV photolysis gives a new band at 475 nm (Figure 
3). Additionally, UV irradiation exhibited faster processes, where an apparent 
isosbestic point owing  to faster photo-induced 4-bzpy release but this soon breaks 
 17 
down upon CO release. Thus, the product distribution from I is wavelength dependent. 
Furthermore, UV photolysis of I leads to CO release as demonstrated below, while no 
CO release was detected by the myoglobin test when an analogous solution was 
irradiated at 453 nm.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. UV-visible spectra of cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 complex (I) in 20/80 
DMSO/H2O solution (6.42 x 10-5 M) as a function of photolysis. Solid line: before 
irradiation. Dotted line: after irradiation with blue light (lirr. = 453 nm) for 2 h. Dashed 
line: spectrum after photolysis of I with 365 nm light for 2 h. Inset: Progressive spectral 
changes during the 365 nm photolysis of I in the same solvent over a period of 2 h 
(note: over time photolysis induced changes showed red shifts in the visible absorption 
bands as benzoylpyridine  and CO are sequentially liberated.)  
 
The temporal spectral changes upon photolysis of aqueous I with a blue LED 
showed a decrease in the MLCT absorption at 415 nm, the appearance of the new 
band at lmax 450 nm with an isosbestic point at c.a. 450 nm (SI Figure S11) over the 
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first 15 min, which supported initial release of 4-bzpy. Further photolysis for another 
105 min led to no further changes. The absence of CO as a product and the general 
unreactivity of the bpy ligands toward photolabilization suggests that the visible light 
stimulated photoreaction gives the monaqua species cis-[Ru(bpy)2(CO)(H2O)]2+ (eq 1). 
The quantum yield fbzpy for this reaction was determined from the spectral changes to 
be 0.075 ± 0.003 (SI Figure S1). 
 
 The 365 nm irradiation of aqueous I displayed a different pattern of spectral 
changes. In the initial stage, the MLCT absorption at 415 nm decreases and the band at 
450 nm becomes evident (Figure 3, inset) within 2 min of irradiation, similar to the 
pattern seen for the longer wavelength photolysis. This behavior suggests the 
formation of cis-[Ru(bpy)2(CO)(H2O)]2+ as an intermediate.  However, continued 365 
nm photolysis is accompanied by evolution of the spectrum to give a new band with 
λmax at 475 nm (Figure 3, inset, dashed line). The peak at 475 nm agrees with the 
spectrum of the diaqua complex cis-[Ru(bpy)2(H2O)2]2+ (IV) [41]. Thus, it appears that 
the intermediate aquo carbonyl complex undergoes secondary photolabilization of CO 
under continued UV photolysis (eq. 2).  Under these conditions the quantum yield for 
the primary photoreaction was determined to be 0.095±0.003 (SI Figure S2), while that 
for the secondary reaction was determined to be fCO = 0.041 ± 0.004 (SI Figure S3). 
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It should be noted that no spectral changes were observed when the solution 
of I was kept in the dark under similar experimental conditions. Alternatively, when the 
solution was photolyzed with blue light to give the spectrum of the intermediate -
[Ru(bpy)2(CO)(H2O)]2+ (V), there was no further spectral change upon storing for 24 h 
in the dark. This indicates that a second high energy photon is necessary for CO 
labilization from V .  
With the aim of better characterizing the photoproducts, the 1H NMR spectra of 
I in DMSO-d6/D2O (20/80, v/v) were recorded before irradiation (Figure 4A), after 
irradiation with blue light (Figure 4B) and after irradiation with UV light (lirr = 350 nm) 
(Figure 4C). The aromatic region in the 1H NMR spectrum before irradiation (Figure 4A) 
shows all the resonances from the non-equivalent sixteen protons of the two bpy 
ligands and five signals from the protons of the 4-bzpy ligand (d 7.1-8.5) (SI Figure S12). 
Based on analogy to the 1H NMR spectra of [Os(bpy)2(CO)(X)]+ (X = Cl, CF3SO3 or H) [42] 
and cis-[Ru(bpy)2(CO)Cl]+[4] the two lowest-field doublets (d 9.31 and d 9.22), can be 
assigned to the ortho-protons of the (bpy)pyridine rings trans each other. After 
irradiation with blue light (Figure 4B) the lowest-field doublet (d 9.31) is shifted 
downfield to d 9.45 and the second doublet (d 9.22) is shifted upfield to d 8.91. 
Analogous changes were observed by Sadler et al. [4] when cis-[Ru(bpy)2(CO)Cl]+ was 
irradiated with white light in DMSO-d6/D2O (5/95, v/v) to give cis-
[Ru(bpy)2(CO)(D2O]2+. The 1H NMR spectra of the blue light photoproduct from I is 
consistent with that of the latter species plus that 
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Figure 4. 1HNMR spectrum of cis-[Ru(bpy)2(4-bzpy)(CO)]2+ in DMSO-d6/D2O (20/80, v/v) 
solution.    A: before irradiation. B: after 2 h irradiation with blue light (lirr = 453 nm). C: after 2 
h irradiation with UV light (lirr  = 365 nm). 
 
of free 4-bzpy, which displays 5 resonances in the aromatic region, the most distinctive 
being at d 8.65 (SI Figure S12). Thus the NMR spectra confirm that the principal 
photoreaction is 4-bzpy labilization according to eq. 1. 
Figure 4C shows the 1H NMR spectra of a solution of I after 2 h irradiation with 
UV light (lirr = 365 nm). This is clearly different to that shown in the Figure 4B for the 
photoproducts from irradiation with blue light. Comparing the 1H NMR spectrum in 
Figure 4C with that of an authentic sample of cis-[Ru(bpy)2(4-bzpy)H2O]2+(VI), which 
was prepared by reaction of cis-[Ru(bpy)2(4-bzpy)NO]3+ with NaN3[43, 44] (SI Figure 
S13),  shows that VI is not the photoproduct.  Thus, since longer term UV irradiation of 
I leads to CO release, with no evidence for formation of VI, we conclude both CO and 
4-bzpy are released to form cis-[Ru(bpy)2(H2O)2]2+ according to eq. 2.  
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The release of CO as a photoproduct was confirmed using the myoglobin (Mb) 
assay method. Figure 5 shows the evolution of the spectrophotometric features of 12 
µM of reduced MbFe(II) in PBS solution upon addition of 24 µM solution of the 
complex cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 dissolved in methanol, followed by 350 nm 
irradiation of the solution. MbFe(II) was freshly obtained from native MbFe(III) upon 
addition of excess sodium dithionite (24 µM) inside an anaerobic chamber. Compound 
I proved to be stable in the dark for 24 h, but it released CO upon illumination at 350 
nm. Upon irradiation for 2 h, the Q band at 557 nm related to MbFe(II) slowly 
disappeared, while bands at 540 and 577 nm characteristic of MbFeCO appeared [45].. 
The Soret band at 435 nm also showed the expected blue shift to 424 nm.  
 
Figure 5. UV-visible spectra of freshly reduced 12 µM MbFe(II) in phosphate buffer solution 
upon addition of cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 complex 24 µM, dissolved in methanol and 
irradiation with UV light (lirr = 350nm). Insert: Expansion in the region around Q bands (540 
and 577 nm)1 
                                                        
1 Fairlamb and co-workers [46] A.J. Atkin;, J.M. Lynam;, B.E. Moulton;, P. Sawle;, R. Motterlini;, N.M. 
Boyle;, M.T. Pryce;, I.J. Fairlamb, Dalton Transactions 40 (2011) 5755-5761. proposed that the myoglobin 
assay can be used to determine the amount of CO liberated from CO-RMs, but certain factors such as 
turbidity caused by poor CO-RM solubility or CO-RM absorbance, affect accurate calculation of Mb-CO 
concentrations. To overcome this problem, Motterlini and co-workers[45] R. Motterlini, J.E. Clark, R. 
Foresti, P. Sarathchandra, B.E. Mann, C.J. Green, Circ. Res. 90 (2002) 17-24. introduced the use of the 
isosbestic points at 510 nm as an internal reference for interconverting species (deoxy-Mb®Mb-CO). 
However, in the present case, it was not possible to observe the isosbestic points, possibly because the 
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In an independent experiment, the headspace over a solution of I was analyzed  by GC-
TCD after 365 nm irradiation, confirming the generation of free CO (SI Figure S14). In 
contrast, there was no CO detected in the Schlenk cuvette headspace after irradiation 
of cis-[Ru(bpy)2(4-bzpy)(CO)]2+ at 453 nm. Quantification was achieved by comparison 
to a calibration curve determined for CO gas. The Schlenk cuvette has an internal 
volume of 30 mL and contained 4.0 mL of the photolysis solution. Given that CO has a 
solubility of 0.92 mM/atm in aqueous solution at 25 oC [47] (the temperature used in 
these experiments), one can calculate a partition coefficient of ~45/1 for CO between 
the gas and liquid phases at equilibrium. The product of the partition coefficient times 
the ratio of gas and liquid volumes (26/4) indicates that, at equilibrium, more than 
99.5% of the CO generated will be in the gas phase of the Schlenk cuvette. The total CO 
released was calculated by taking into account this partitioning. Thus, by the GC 
methods, it was determined that a sample (15 mg) of I in DMSO/H2O (20/80, v/v) 
solution photolyzed for 2 h at 365 nm released 0.82±0.05 equivalents of CO per mole 
of complex.  
 Photolysis experiments were also performed with complex II. Electronic spectra 
changes during the photolysis with blue light in DMSO/H2O (5/95, v/v) solution showed 
a decrease in the MLCT absorption at 440 nm and formation of a new band with a lmax 
at 475 nm within 10 min (Figure 6). Further changes in the electronic spectrum were 
not observed even after 110 min additional photolysis or for a sample photolyzed for 
30 min with blue light then stored in the dark for 24 h. In addition, there were no 
                                                                                                                                                                  
electronic spectrum of the cis-[Ru(bpy)2(H2O)2]2+ product shows a band in the same region (figure 3, 
dashed line). The overlapping bands makes the method ineffective for quantification of released CO. 
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spectral changes for a DMSO/H2O (5/95, v/v) solution of II kept in the dark under 
otherwise similar experimental conditions.   
 The photoreaction was also monitored by 1H NMR spectroscopy (Figure 7). The 
1H NMR spectra of the photoproduct from blue light photolysis of II (Figure 7B) is not 
the same as that for the cis-[Ru(bpy)2(H2O)2]2+ (Figure 4C).  Thus, the d 8.65 signal 
indicates that the 4-bzpy ligand undergoes labilization to give the aqua species cis-
[Ru(bpy)2(H2O)Cl]+ (eq. 3), since this signal is observed in the 1H NMR spectra for the 
free ligand 4-bzpy (SI Figure S12).  
 
  
 Quantitative evaluation of photo-induced changes in the absorption spectrum 
gave the quantum yield for 4-bzpy photodissociation from II fbzpy = 0.131±0.005 (SI 
Figure S4. 
 When a solution of II in DMSO/H2O (5/95, v/v) was irradiated with 453 nm light 
in presence of 2 equivalents of guanine (G), the spectral changes were somewhat 
different.  An initial decrease in the MLCT absorption of II at 440 nm was accompanied 
by the growth of a band at 475 nm over the first 30 min, consistent with formation of 
cis-[Ru(bpy)2(H2O)Cl]+ (eq. 3).  When the resulting solution is left in the dark for 24 h 
with stirring, the MLCT absorption at 475 nm decreased and a new absorption 
appeared at 510 nm (Figure 6-dashed line). This result suggests that the cis-
[Ru(bpy)2(H2O)Cl]+ photoproduct reacts with G to give the cis-[Ru(bpy)2(G)(Cl)]+, (eq. 
4), although excess guanine was used in this experiment, we believe that only the 
mono adduct was formed.  Earlier studies by Reedijk and co-workers showed that cis-
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[Ru(bpy)2Cl2] forms only a N(7) mono adduct with 9-ethylguanine even under strong 
conditions and precipitation of the halides [[48].  
 
Figure 6. Solid line: Absorption spectra changes accompanying photolysis of II (1.18 x 10-4 M), 
in DMSO/H2O (5/95, v/v) solution for 2 h, lirr = 453 nm. Dashed line: UV-vis spectra of II (1.18 x 
10-4 M) after 453 nm irradiation in presence of 2 equivalents of guanine (G) in DMSO/H2O 
(5/95, v/v) solution followed by leaving in the dark for 24 h with stirring. 
 
 
 Figure 7 shows the 1H NMR spectra obtained for a solution of II in DMSO-
d6/D2O (5/95, v/v) containing 2 equivalents of guanine before photolysis and after the 
solution was irradiated and left in the dark for 24 h. Only one type of metal-nucleobase 
was observed as revealed by appearance of a new singlet resonance at 6.41 ppm. This 
resonance can be assigned to the H8 of guanine in the N(7) Ru-guanine mono adduct, 
compared to free guanine which shows this at 7.40 ppm. This shift is consistent with 
the shielding effect induced by the ring current of the bpy ligands [13,[48].  
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Figure 7. 1H NMR spectrum of cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6) in solution DMSO-d6/D2O (5/95, 
v/v). A: before irradiation; B: after irradiation with blue light for 2 h; C: in presence of 2 
equivalents of guanine (G) in the dark; D: in presence of 2 equivalents of guanine (G), after 
irradiation with blue light for 2 h and then left in the dark for 24 h under stirring. The asterisk 
(*) indicates H8 proton of free guanine and (*G) indicates H8 proton of guanine coordinated 
 
Summary and Conclusions 
We have prepared a CO-bound ruthenium complex I containing 4-
benzoylpyridine aiming to controlled photorelease CO and also to generate potentially 
reactive ruthenium products. Interestingly, complex I quantitatively photoreleases CO 
upon UV (365 nm) irradiation, but not upon blue light (453 nm) irradiation. However, 
the 4-bzpy was photoreleased at either excitation wavelength. Complex II, which does 
not contain CO was also able to photorelease 4-bzpy. Indeed, guanine was showed to 
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bind to the ruthenium aquo species cis-[Ru(bpy)2(H2O)Cl]+ generated by the latter 
photoreaction, suggesting that these complexes might interact with DNA, thereby 
mimicking a platinum-based drug. Along these lines, such dual or single ligand 
photorelease under controlled wavelengths might be further explored for therapeutic 
purposes. 
   
Acknowledgments 
The authors are thankful to Brazilian agencies CAPES, CNPq (L. G. F. Lopes 
303732/2014-8; E. H. S. Sousa 312030/2015-0), FUNCAP (PPSUS 12535691-9) for 
financial support.  We thank Zhi Li of UC Santa Barbara for his help with quantum yield 
measurements and with CO quantification.   
Supporting Information:  Figures S1 to S14. 
 
References 
[1] J.R. Lakowicz, Principles of Fluorescence Spectroscopy, Kluwer Accademic/Plenum 
Publishers,New York, 1999. 
[2] T.S. Kamatchi, N. Chitrapriya, S.K. Kim, F.R. Fronczek, K. Natarajan, European 
Journal of Medicinal Chemistry 59 (2013) 253-264. 
[3] C. Mari, V. Pierroz, S. Ferrarib, G. Gasser, Chemical Science 6 (2015) 2660-2686. 
[4] L. Salassa, T. Ruiu, C. Garino, A.M. Pizarro, F. Bardelli, D. Gionolio, A. Westendorf, 
P.J. Bednarski, C. Lamberti, R. Gobetto, P.J. Sadler, Organometallics 29 (2010) 6703-
6710. 
 27 
[5] L. Salassa, E. Borfecchia, T. Ruiu, C. Garino, D. Gianolio, R. Gobetto, P.J. Sadler, M. 
Cammarata, M. Wulff, C. Lamberti, Inorganic Chemistry 49 (2010) 11240–11248. 
[6] W. H. Ang, P.J. Dyson, European Journal of Inorganic Chemistry (2006) 4003-4018. 
[7] L. Zayat, C. Calero, P. Albores, L. Baraldo, R. Etchenique, J Am Chem Soc 125 (2003) 
882-883. 
[8] L. Zayat, O. Filevich, L.M. Baraldo, R. Etchenique, Philos Trans A Math Phys Eng Sci 
371 (2013) 20120330. 
[9] M.G. Sauaia, F.D. Oliveira, A.C. Tedesco, R.S. da Silva, Inorganica Chimica Acta 355 
(2003) 191-196. 
[10] F.O.N. Silva, S.X.B. Araujo, A.K.M. Holanda, E. Meyer, F.A.M. Sales, H.C.N. 
Diogenes, I.M.M. Carvalho, I.S. Moreira, L.G.F. Lopes, European Journal of Inorganic 
Chemistry (2006) 2020-2026. 
[11] T. Sjöstrand, Nature Reviews Drug Discovery 164 (1949) 580-581. 
[12] R. Motterlini, L.E. Otterbein, Nature Reviews Drug Discovery 9 (2010) 728-743. 
[13] R. D. Rimmer, H. Richter, P.C. Ford, Inorganic Chemistry 49 (2010) 1180-1185. 
[14] R.D. Rimmer, A.E. Pierri, P.C. Ford, Coordination Chemistry Reviews 256 (2012) 
1509-1519. 
[15] U. Schatzschneider, British Journal of Pharmacology 172 (2015) 1638-1650. 
[16] A. Radu, R. Conde, C. Fontolliet, G. Wagnieres, H.V. den Bergh, P. Monnier, 
Gastrointestinal Endoscopy 57 (2003) 897-905. 
[17] L. Brancaleon, H. Moseley, Lasers in Medical Science 17 (2002) 173-186. 
[18] M.H. Hanigan, P. Devarajan, Cancer Ther. 1 (2003) 47-61. 
[19] B.P. Sullivan, D.J. Salmon, T.J. Meyer, Inorganic Chemistry 17 (1978) 3334-3341. 
[20] Enraf-Nonius, COLLECT, Delft (1997-2000). 
 28 
[21] Z. Otwinowski, W. Minor, Meth. Enzymol. 276 (1997) 307. 
[22] R.H. Blessing, Acta Crystallographica Section A 51 (1995) 33-38. 
[23] G.M. Sheldrick, Acta Crystallographica Section A 64 (2008) 112-122. 
[24] G.M. Sheldrick, SHELXL-97., Program for Crystal Structures Analysis, University of 
Gottingen, Gottingen, Germany (1997). 
[25] J.G. Calvert, J.N. Pitts, Photochemistry, J.Wiley and Sons,New York, 1967. 
[26] G.A. Crosby, J.N. Demas, J. Phys. Chem. 75 (1971) 991-1024. 
[27] D.A. Freedman, S. Kruger, C. Roosa, C. Wymer, Inorganic Chemistry 45 (2006) 
9558-9568. 
[28] R. Llanguri, J.J. Morris, W.C. Stanley, E.T. Bell-Loncella, M. Turner, W.J. Boyko, C.A. 
Bessel, Inorganica Chimica Acta 315 (2001) 53-65. 
[29] M. Brissard, O. Convert, M. Gruselle, C. Guyard-Duhayon, R. Thouvenot, Inorganic 
Chemistry 42 (2003) 1378-1385. 
[30] H. Ishida, K. Tanaka, M. Morimoto, T. Tanaka, Organometallics 5 (1986) 724-730. 
[31] E. Fujita, Coord Chem Rev. 185-186 (1999) 373-384. 
[32] N.C. Yumata, G. Habarurema, J. Mukiza, T.I.A. Gerber, E. Hosten, F. Taherkhani, M. 
Nahali, Polyhedron 62 (2013) 89-103. 
[33] M. Busby, P. Matousek, M. Towrie, I.P. Clark, M. Motevalli, F. Hartl, A. Vlček Jr., 
Inorganic Chemistry 43 (2004) 4523-4530. 
[34] D.L. Paiva, G.M. Lampman, G.S. Kriz, J.R. Vyvyan, Introduction to Spectroscopy, 
Cengage Learning,2009. 
[35] T.R. Johnson, B.E. Mann, I.P. Teasdale, H. Adams, R. Foresti, C.J. Greenb, R. 
Motterlini, Dalton Transactions (2007) 1500-1508. 
 29 
[36] R. Llanguri, J.J. Morris, W.C. Stanley, E.T. Bell-Loncella, M. Turner, W.J. Boyko, C.A. 
Bessel, Inorg. Chim. Acta 315 (2001) 53-65. 
[37] M. Brissard, O. Convert, M. Gruselle, C. Guyard-Duhayon, R. Thouvenot, Inorganic 
Chemistry 42 (2003) 1378-1385. 
[38] Y. Bai, G.S. Zheng, D.B. Dang, Y.N. Zheng, P.T. Ma, Spectrochim Acta A Mol Biomol 
Spectrosc. 79 (2011) 1338-1344. 
[39] B. Durham, S.R. Wilson, D.J. Hodgson, T.J. Meyer, Journal of American Chemical 
Society 102 (1980) 600-607. 
[40] D.M. Klassen, G.A. Crosby, J. Chem. Phys. 48 (1968) 1853-1858. 
[41] B. Durham, S.R. Wilson, D.J. Hodgson, T.J. Meyer, Journal American Chemical 
Society 102 (1980) 600-607. 
[42] R. Gobetto, C. Nervi, B. Romanin, L. Salassa, M. Milanesio, G. Croce, 
Organometallics 22 (2003) 4012-4019. 
[43] D.W. Raichart, H. Taube, Inorganic Chemistry 11 (1972) 999-1002. 
[44] T.J. Meyer, F.J. Miller, Journal American Chemical Society 93 (1971) 1294-1294. 
[45] R. Motterlini, J.E. Clark, R. Foresti, P. Sarathchandra, B.E. Mann, C.J. Green, Circ. 
Res. 90 (2002) 17-24. 
[46] A.J. Atkin;, J.M. Lynam;, B.E. Moulton;, P. Sawle;, R. Motterlini;, N.M. Boyle;, M.T. 
Pryce;, I.J. Fairlamb, Dalton Transactions 40 (2011) 5755-5761. 
[47] R. Bartino, Iupac Solubility Data Series; Cargill, R. W., Oxford, U. K., 1990. 
[48] P.M. van Wet, J.G. Haasnoot, J. Reedijk, Inorganic Chemistry 33 (1994) 1934-1939. 
 
 
